QPT Fundamental Analysis - QUEST PHARMATECH INC

Fundamental Rating

We assign a fundamental rating of 1 out of 10 to QPT. QPT was compared to 25 industry peers in the Biotechnology industry. QPT may be in some trouble as it scores bad on both profitability and health. QPT is valued expensive and it does not seem to be growing.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year QPT has reported negative net income.

In the past year QPT has reported a negative cash flow from operations.

QPT had negative earnings in 4 of the past 5 years.

QPT had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

With an excellent Return On Assets value of -1.06%, QPT belongs to the best of the industry, outperforming 88.00% of the companies in the same industry.

The Return On Equity of QPT (-1.11%) is better than 92.00% of its industry peers.

		Industry Rank	Sector Rank
ROA	-1.06%
ROE	-1.11%
ROIC	N/A

ROA(3y)-87.47%

ROA(5y)-49.52%

ROE(3y)-91.33%

ROE(5y)-51.91%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for QPT so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

QPT has about the same amout of shares outstanding than it did 1 year ago.

The number of shares outstanding for QPT has been increased compared to 5 years ago.

Compared to 1 year ago, QPT has a worse debt to assets ratio.

2.2 Solvency

An Altman-Z score of 2.41 indicates that QPT is not a great score, but indicates only limited risk for bankruptcy at the moment.

With an excellent Altman-Z score value of 2.41, QPT belongs to the best of the industry, outperforming 88.00% of the companies in the same industry.

A Debt/Equity ratio of 0.05 indicates that QPT is not too dependend on debt financing.

With a decent Debt to Equity ratio value of 0.05, QPT is doing good in the industry, outperforming 72.00% of the companies in the same industry.

		Industry Rank	Sector Rank
Debt/Equity	0.05
Debt/FCF	N/A
Altman-Z	2.41

ROIC/WACCN/A

WACCN/A

2.3 Liquidity

QPT has a Current Ratio of 0.07. This is a bad value and indicates that QPT is not financially healthy enough and could expect problems in meeting its short term obligations.

QPT's Current ratio of 0.07 is on the low side compared to the rest of the industry. QPT is outperformed by 76.00% of its industry peers.

A Quick Ratio of 0.07 indicates that QPT may have some problems paying its short term obligations.

The Quick ratio of QPT (0.07) is worse than 76.00% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	0.07
Quick Ratio	0.07

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The earnings per share for QPT have decreased strongly by -101.87% in the last year.

EPS 1Y (TTM)-101.87%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%180.39%

Revenue 1Y (TTM)N/A

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for QPT!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

QUEST PHARMATECH INC

TSX-V:QPT (7/29/2025, 7:00:00 PM)

0.04

0 (-11.11%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences

GICS IndustryBiotechnology

Earnings (Last)06-27 2025-06-27

Earnings (Next)09-22 2025-09-22

Inst OwnersN/A

Inst Owner ChangeN/A

Ins Owners2.27%

Ins Owner ChangeN/A

Market Cap6.77M

Analysts0

Price TargetN/A

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)N/A

PT rev (3m)N/A

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)N/A

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	N/A
P/FCF	N/A
P/OCF	N/A
P/B	0.31
P/tB	0.31
EV/EBITDA	N/A

EPS(TTM)0

EYN/A

EPS(NY)N/A

Fwd EYN/A

FCF(TTM)0

FCFYN/A

OCF(TTM)0

OCFYN/A

SpS0

BVpS0.13

TBVpS0.13

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-1.06%
ROE	-1.11%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	N/A
FCFM	N/A

ROA(3y)-87.47%

ROA(5y)-49.52%

ROE(3y)-91.33%

ROE(5y)-51.91%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

F-Score2

Asset Turnover0

Health

		Industry Rank	Sector Rank
Debt/Equity	0.05
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	N/A
Cap/Sales	N/A
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	0.07
Quick Ratio	0.07
Altman-Z	2.41

F-Score2

WACCN/A

ROIC/WACCN/A

Cap/Depr(3y)N/A

Cap/Depr(5y)N/A

Cap/Sales(3y)N/A

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-101.87%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%180.39%

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)N/A

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%N/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y33.58%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y23.05%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y22.86%

OCF growth 3YN/A

OCF growth 5YN/A

QUEST PHARMATECH INC (QPT.CA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens